CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 80 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,145,301 | -6.1% | 538,579 | +7.7% | 0.03% | -15.4% |
| Q3 2022 | $3,350,000 | +32.6% | 500,000 | -16.7% | 0.04% | +34.5% |
| Q2 2022 | $2,526,000 | +36.8% | 600,000 | +9.5% | 0.03% | +45.0% |
| Q1 2022 | $1,847,000 | +7.0% | 548,090 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $1,726,000 | +6.0% | 548,090 | +10.0% | 0.02% | 0.0% |
| Q3 2021 | $1,629,000 | -22.5% | 498,090 | 0.0% | 0.02% | -16.7% |
| Q2 2021 | $2,102,000 | +21.3% | 498,090 | +43.5% | 0.02% | +9.1% |
| Q1 2021 | $1,733,000 | -60.5% | 347,219 | 0.0% | 0.02% | -64.5% |
| Q4 2020 | $4,389,000 | -17.3% | 347,219 | -35.7% | 0.06% | -23.5% |
| Q3 2020 | $5,306,000 | +6.1% | 540,354 | +7.5% | 0.08% | +6.6% |
| Q2 2020 | $5,003,000 | +25.2% | 502,783 | +11.3% | 0.08% | -5.0% |
| Q1 2020 | $3,995,000 | +35.9% | 451,900 | +41.8% | 0.08% | +105.1% |
| Q4 2019 | $2,939,000 | -20.4% | 318,638 | +3.5% | 0.04% | -18.8% |
| Q2 2019 | $3,693,000 | +42.8% | 307,738 | +43.6% | 0.05% | +41.2% |
| Q1 2019 | $2,587,000 | +117.0% | 214,369 | +125.7% | 0.03% | +100.0% |
| Q4 2018 | $1,192,000 | -78.1% | 95,000 | -74.2% | 0.02% | -58.5% |
| Q3 2017 | $5,432,000 | +7.7% | 368,243 | +1.8% | 0.04% | -2.4% |
| Q2 2017 | $5,045,000 | +46.4% | 361,667 | +79.0% | 0.04% | +50.0% |
| Q1 2017 | $3,447,000 | -5.9% | 202,072 | -43.3% | 0.03% | -6.7% |
| Q4 2016 | $3,665,000 | +9.6% | 356,215 | +7.7% | 0.03% | -3.2% |
| Q3 2016 | $3,345,000 | +9.6% | 330,837 | +103.5% | 0.03% | -13.9% |
| Q3 2015 | $3,051,000 | -24.3% | 162,534 | -39.9% | 0.04% | +56.5% |
| Q2 2015 | $4,028,000 | +104.6% | 270,522 | +108.1% | 0.02% | -14.8% |
| Q1 2015 | $1,969,000 | +52.6% | 130,000 | +27.1% | 0.03% | 0.0% |
| Q3 2014 | $1,290,000 | -17.2% | 102,280 | -33.7% | 0.03% | -22.9% |
| Q2 2014 | $1,558,000 | -60.4% | 154,247 | -47.3% | 0.04% | -67.6% |
| Q1 2014 | $3,938,000 | – | 292,773 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
| Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
| TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
| BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
| Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
| AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
| INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
| Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |